Adar Poonawalla, CEO, Serum Institute of India (SII) said on Sunday that the Covishield, India's first Covid-19 vaccine will roll out in the coming weeks....
Union Health Minister Harsh Vardhan on Sunday said the drug regulator's approval of two coronavirus vaccines for emergency use was a watershed moment in the country's battle against the deadly virus....
Even as farmers continued to protest on the Delhi borders for the 39th day on Sunday, the Congress acccused the Union government of showing "apathy" towards 'annadatas' braving cold and rain to save their dignity. ...
Rain lashed the NCR-Delhi area for the second consecutive day on Sunday, with 1 mm rainfall recorded in the morning hours, weather officials said....
Congress leader Rahul Gandhi on Sunday slammed the government on the agitation by farmers, whom he equated with 'satyagrahis' who will take their rights from the government....
With 18,177 new coronavirus infections and 217 deaths in the past 24 hours, India's overall tally stood at 1,03,23,965 on Sunday, while the death toll touched 1,49,435, the Ministry of Health and Family Welfare said....
Eleven months after the first case of deadly coronavirus was detected in India, Drug Controller General of India (DCGI) V.G. Somani on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use, paving the way for their roll-out and administration to millions....
In the last 24 hours, 494 new Covid cases and 13 new deaths have been reported in Delhi while 40 people have been detected with new corona strain. All the 40 persons have been admitted to LNJP hospital. ...
Bharat Biotech on Saturday announced successful recruitment of 23,000 volunteers, and continued progress towards achieving the goal of 26,000 participants for phase-III clinical trial of its coronavirus vaccine 'Covaxin' across multiple sites in India....
The All India Drug Action Network (AIDAN) said it is shocked to learn of the SEC's recommendation to grant REU approval to Bharat Biotech's COVAXIN in "clinical trial mode" and "specially in the context of infection by mutant strains". ...
